Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Leerink Partnrs cut their Q2 2024 EPS estimates for shares of Adaptimmune Therapeutics in a research report issued on Wednesday, May 15th. Leerink Partnrs analyst J. Chang now forecasts that the biotechnology company will post earnings of ($0.17) per share for the quarter, down from their previous […]
Boston Partners boosted its stake in Arch Resources, Inc. (NYSE:ARCH – Free Report) by 107.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,803 shares of the energy company’s stock after purchasing an additional 7,136 shares during the quarter. Boston Partners owned about 0.08% […]
GSK plc (NYSE:GSK) Given Average Rating of Hold by Brokerages wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
IDEAYA Biosciences (IDYA) Outperform Rating Reiterated at Wedbush dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Gallacher Capital Management LLC purchased a new stake in shares of Arch Resources, Inc. (NYSE:ARCH – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 2,476 shares of the energy company’s stock, valued at approximately $411,000. A number of […]